NanoHealth
 | |
| Company type | Social enterprise |
|---|---|
| Industry | Healthcare |
| Founded | 2014 |
| Headquarters | Hyderabad, India |
Key people | Manish Ranjan (CEO) |
| Website | www |
NanoHealth is a social enterprise that focuses on managing chronic diseases such as diabetes, asthma, and hypertension in Indian urban slums and low income communities. It was the 2014 recipient of the Hult Prize.
History
[edit]NanoHealth was founded in 2014 by a group of five alumni from the Indian School of Business in Hyderabad. Its primary focus is the creation of a network of local community health workers called "Saathis". These workers, who are trained and certified by the company, use the "Doc-in-a-Bag", a low-cost diagnostic tool for chronic disease management. In 2014 the company was awarded the Hult Prize, the first ever Indian team to receive the award.[1][2] Two years after the founding, Pagitipati family bought over most of the non-active co-founders.
In 2018 they held an ICO to non-credentialed US investors.
Partners
[edit]- GVK BIO's HEART (Health Emphasized Analytics and Reporting Tool), a cloud-based healthcare analytics framework[3]
- Youth for Seva, an organization in India providing young volunteers to work in schools, NGOs, government hospitals and other organizations in the social sector[4]
- Tabeeb, a US-based health care firm with an international virtual network of specialist doctors [5]
Awards
[edit]References
[edit]- ^ Thorpe, Devin (22 October 2014). "President Clinton Presents Hult Prize To Indian Social Entrepreneurs". Forbes. Retrieved 31 March 2015.
- ^ Madhav, N. (14 October 2014). "NanoHealth expects to launch operations by January". Business Standard. Retrieved 31 March 2015.
- ^ The Economic Times (22 September 2014). "NanoHealth ties up with GVK BIO for healthcare services". Retrieved 31 March 2015.
- ^ Murthy, Neeraja (10 October 2014). "Out of the box service". The Hindu. Retrieved 31 March 2015.
- ^ PR Web (17 March 2015). "Press release: NanoHealth Partners With Tabeeb to Provide an End-To-End Solution for Chronic Diseases". Retrieved 31 March 2015.